GSK PLC GSK shares rose 1.06% to £13.34 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed yesterday at p1,341. ...

TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The company’s shares opened today at $34.81.

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2278.60 as on 16 Dec, 2024, 03:31 PM IST. On previous day, the GSK Pharma Share Price ...